Abstract accepted as oral presentation at the DEGRO conference 2018!

In 2016, Irmgard Helmbold, study physician,  presented some preliminary findings on hypofractionation and acute toxicity among prostate cancer patients at the conference of the German Society for Radiooncology (DEGRO) to introduce the REQUITE study more widely. She and the co-authors like to present updated results at this year’s DEGRO conference, so we are very pleased that the abstract on hypofractionation among prostate cancer patients has been accepted as a talk for the German Society for Radiooncology conference in June 2018.

The 24th Annual Meeting of the German Society for Radiation Oncology, Deutschen Gesellschaft fur Radioonkologie (DEGRO), is organized by MCI Deutschland GmbH and will be held during Jun 21 - 24, 2018 at Congress Center Leipzig in Germany. The target audience for this medical event is Radiation Oncologists, Oncologists. The conference topics are:

• Neurooncology
• Pediatric Radiation Oncology
• High-precision techniques
• Modern imaging techniques in therapy planning
• Protons and heavy ions
• radioimmunotherapy
• Molecular genetics in radiation oncology
• palliative Medicine
• breast cancer
• prostate cancer
• Interdisciplinary discussions
• Teaching and training at national and European level